Form 4: Illumina Director Anna Richo Receives Stock Grant

Illumina, Inc. director Anna Richo was granted 2,072 restricted stock units as part of her compensation package.

Summary

• Director Anna Richo acquired 2,072 shares of Illumina, Inc. (ILMN) common stock via a restricted stock unit (RSU) grant.
• The transaction occurred on May 21, 2026, at a valuation of $144.83 per share.
• Following this transaction, the reporting person holds a total of 8,527 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of the restricted stock units is contingent upon the director's continued service to the company.

Future Outlook

The restricted stock units vest on the earlier of the one-year anniversary of the grant or the date immediately preceding the next annual stockholders' meeting, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice in the biotechnology and life sciences sector to ensure long-term alignment between leadership and investor outcomes.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices among large-cap life sciences companies like Thermo Fisher Scientific and Agilent Technologies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 2,072 restricted stock units upon the one-year anniversary or the next annual meeting.

Key Dates

Keywords

Illumina, ILMN, Form 4, Insider Trading, Director Compensation, Equity Grant